Inflammatory and nutritional markers in colorectal cancer: Implications for prognosis and treatment  

作　　者：Mesut Tez 

机构地区：[1]Department of Surgery,University of Health Sciences,Ankara City Hospital,Ankara 06800,Türkiye

出　　处：《World Journal of Clinical Oncology》2024年第10期1264-1268,共5页世界临床肿瘤学杂志（英文）

摘　　要：The prognosis of colorectal cancer(CRC)patients with peritoneal metastasis remains poor despite advancements in detection and treatment.Preoperative inflammatory and nutritional markers have emerged as significant predictors of prognosis in CRC,potentially guiding treatment decisions and improving patient outcomes.This editorial explores the prognostic value of markers such as the neutrophil-to-lymphocyte ratio,hemoglobin,and serum albumin levels.By integrating these markers into prognostic models,clinicians can better stratify patients,personalize treatment strategies,and ultimately enhance clinical outcomes.This review highlights the importance of these markers in providing a comprehensive assessment of patient condition and underscores the need for further research to validate their clinical utility and uncover underlying mecha-nisms.

关 键 词：Colorectal cancer Peritoneal metastasis Neutrophil-to-lymphocyte ratio HEMOGLOBIN Serum albumin Inflammatory markers Nutritional markers PROGNOSIS Preoperative markers Personalized treatment 

分 类 号：R730.5[医药卫生—肿瘤]